AI brain monitoring
Open for applications
AI brain monitoring
21-100 employees
Open for applications
21-100 employees
To improve human health by enabling rapid, targeted interventions through advanced brain analytics.
The brain has long been considered one of the most mysterious fields of medicine - and psychiatric and neurological diseases therefore one of the least understood. Better access to real-time brain data, however, could change this. That’s exactly what Beacon Biosignals is hoping to deliver.
Beacon Biosignals has developed a scaleable electroencephalogram (EEG) analytics platform that leverages AI to more accurately and insightfully manage brain data. Its capabilities run from analysing existing data, to identifying and standardizing neorobiomarkers, to continuously aggregating and analyzing trial data.
The hope is that this will help clinical brain researchers carry out faster and more accurate work, ultimately accelerating the pace of treatment development in neurology. It’s a smart new AI application, and Beacon Biosignals is acquiring new companies to scale and receiving handsome funding - but for that reason the company isn’t alone in pursuing it. Bitbrain is also developing neurology AI, although with a tighter focus on product development. This may help differentiate Beacon Biosignals in what is still a relatively new market area.
Kirsty
Company Specialist at Welcome to the Jungle
Nov 2021
$27m
SERIES A
Jun 2019
$3m
SEED
Beacon Hill, Boston, MA
Jarrett Revels
(CTO)Previously a Software Engineer at MissionFocus, who then moved into various engineering and research roles at MIT.
Jacob Donoghue
(CEO)Completed a Neuroscience PhD at MIT, and received his MD from Harvard Medical School. Subsequently carried out research for Cyberkinetics Neurotechnology Systems and Massachusetts General Hospital.
Brandon Westover
(Co-founder)Received his MD from Washington University School of Medicine, then took up a Neurology residency at Harvard Medical School. Alongside his work at Beacon Biosignals, is also an HST Faculty member at MIT and a Neurologist/Medical AI Researcher at Massachusetts General Hospital.
Syd Cash
(Co-founder)An Associate Professor at Harvard Medical School, who also leads the Center for Neurotechnology and Neurorecovery at MGH.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 6 more jobs at Beacon Biosignals